Mastitis Mouse Body Temperature Monitoring Experiment: Study Design, Measurement Methods, and Precli

The mastitis mouse body temperature monitoring experiment is a preclinical study that tracks core temperature changes in mice following experimentally induced mammary gland inflammation, providing a quantitative systemic biomarker of infection severity and therapeutic response. By combining standardized temperature measurement techniques with histopathology, cytokine profiling, and bacterial load quantification, this model supports efficacy evaluation of anti-inflammatory agents, antibiotics, and biological products. This article outlines the study design, sample requirements, measurement methods, and regulatory considerations for reliable temperature-based endpoints in murine mastitis research.

Technical Overview

Mastitis is an inflammatory disease of the mammary gland that can be reproduced in mice through intramammary inoculation of pathogenic microorganisms or purified endotoxin. In this model, body temperature serves as a sensitive, non-invasive, and dynamically trackable indicator of systemic inflammatory progression. During the early inflammatory phase, pyrogenic cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) drive a febrile response, whereas severe endotoxemia or sepsis can progress to pronounced hypothermia, a recognized prognostic sign in murine systemic inflammation models.

A typical monitoring experiment quantifies baseline core temperature during acclimation, records the time-course thermal response following inoculation, and derives analytical parameters such as maximal temperature change (ΔTmax) and fever index (area under the temperature–time curve). These thermal endpoints are correlated with mammary gland pathology scores, myeloperoxidase (MPO) activity, bacterial colony counts, and cytokine concentrations to establish a comprehensive assessment framework. Study conduct should comply with institutional animal care and ethics requirements, the ISO 10993 series principles for biological evaluation where device- or biomaterial-related systemic effects are investigated, and laboratory animal environmental standards such as GB 14925, with reporting aligned to ARRIVE 2.0 guidelines.

Testing Samples

Animal Models

Specific pathogen-free (SPF) female mice, typically 6 to 10 weeks of age and weighing 18 to 25 g, are used. Common strains include C57BL/6, BALB/c, and ICR (KM) mice. Lactation-stage models generally employ dams at 7 to 10 days postpartum, as the lactating mammary duct system is more susceptible to intraductal inoculation. Nulliparous models with hormonally primed mammary glands are also accepted for specific study designs. Animals are housed under barrier conditions with controlled temperature (20–26 °C), humidity (40–70%), and a 12-hour light/dark cycle.

Pathogen Inoculum and Reagents

Standard challenge materials include clinical or reference strains of

• Staphylococcus aureus (gram-positive, acute suppurative mastitis)
• Escherichia coli (gram-negative, endotoxin-driven systemic response)
• Streptococcus uberis or Streptococcus agalactiae (streptococcal mastitis)
• Lipopolysaccharide (LPS) endotoxin for sterile inflammation models

Bacterial suspensions are prepared in sterile phosphate-buffered saline and standardized by optical density or serial dilution plating to a defined inoculum, commonly in the range of 10² to 10⁴ colony-forming units (CFU) per gland depending on strain virulence and study objectives.

Test Substances

Candidate materials under evaluation may include antibiotics, non-steroidal anti-inflammatory drugs, corticosteroids, botanical anti-inflammatory extracts, monoclonal antibodies, probiotic formulations, and biomaterial-derived products. Test substances are administered via clinically relevant routes (oral gavage, intraperitoneal, subcutaneous, or intramammary) at predefined time points relative to inoculation, with appropriate vehicle and positive-control arms.

Testing Items

The core testing items for the temperature monitoring experiment include:

• Baseline core body temperature recorded during a 3-day acclimation and pre-dose period
• Time-course core temperature measurements at predefined intervals, typically every 2 to 4 hours during the first 24 hours and every 12 hours thereafter through 72 hours
• Maximal temperature change (ΔTmax) relative to individual baseline values
• Fever index, calculated as the area under the temperature–time deviation curve
• Hypothermia severity grading for assessment of systemic deterioration and humane endpoint decisions
• Correlation endpoints, including mammary gland histopathology scoring, MPO activity, bacterial burden in gland homogenates, and serum cytokine levels (IL-1β, IL-6, TNF-α)
• Clinical observation scores covering activity, grooming, appetite, and local gland signs (erythema, edema, induration)

Testing Methods

Rectal Probe Thermometry

A calibrated digital rectal thermometer with a lubricated flexible probe is inserted to a consistent depth of approximately 1 to 2 cm until a stable reading is obtained. Measurements are performed by trained personnel in a standardized sequence and at consistent time points to reduce circadian and handling variability. Rectal thermometry remains the reference method for spot-check core temperature confirmation.

Infrared Thermal Imaging

Non-contact infrared thermography captures surface temperature maps of the mammary and abdominal regions. Thermograms are acquired under fixed ambient conditions, constant camera distance and angle, and after a standard acclimation period in the imaging area. Regional temperature differentials between inoculated and contralateral glands provide a localized inflammation index that complements core temperature data.

Wireless Telemetry and Microchip Transponders

Subcutaneously implanted temperature transponders or programmable telemetric devices enable continuous or high-frequency automated recording with minimal handling stress. This approach improves temporal resolution, reduces operator-induced artifacts, and is particularly valuable for capturing nocturnal febrile peaks in mice, a nocturnal species.

Experimental Workflow

The standard protocol proceeds as follows: acclimation of animals for at least 7 days; baseline temperature recording over 3 consecutive days; randomization and blinding of treatment allocation; induction of light anesthesia (isoflurane or ketamine–xylazine); exposure of the teat orifice and inoculation of the challenge suspension through the teat canal into the fourth (inguinal) mammary gland using a fine blunt cannula; administration of test substance per the dosing schedule; serial temperature acquisition across the 72-hour observation window; and terminal sample collection under deep anesthesia for histological, microbiological, and biochemical analysis. Humane endpoints, including sustained hypothermia below a protocol-defined threshold, are pre-specified in the approved animal use protocol.

Data Processing and Statistical Analysis

Individual temperature values are expressed as absolute readings and as deviations from baseline (ΔT). Fever index is computed by trapezoidal integration of the ΔT–time curve. Group comparisons employ repeated-measures analysis of variance (ANOVA) with appropriate post-hoc tests, and correlation analysis links thermal parameters with inflammatory markers. All raw records, calibration certificates for measurement devices, and analysis scripts are archived to ensure traceability and reproducibility.

Applications

• Preclinical efficacy screening of anti-mastitis drug candidates, including antibiotics, anti-inflammatory agents, and biological therapies
• Comparative pathogenesis research translating murine findings to bovine and caprine mastitis control strategies in dairy science
• Endotoxemia and sepsis mechanism studies using temperature trajectory as a systemic severity biomarker
• Evaluation of botanical extracts, functional feed additives, and immunomodulatory formulations under standardized inflammatory challenge
• Systemic safety and pyrogenic response assessment supporting biological evaluation programs consistent with the ISO 10993-11 framework for systemic toxicity endpoints
• Method development and instrument validation for non-contact thermographic imaging in laboratory animal research

FAQ

Why is body temperature monitored in a mastitis mouse model? Body temperature reflects the systemic component of the inflammatory response. Fever indicates pyrogenic cytokine activation, while progressive hypothermia signals severe endotoxemia. Temperature trajectories therefore provide early, quantitative, and longitudinally trackable evidence of disease progression and treatment effect.

What is the normal baseline body temperature of mice?Under standard housing conditions, healthy adult mice typically maintain a core temperature of approximately 36.5 to 38.5 °C, with measurable circadian fluctuation. Each animal therefore serves as its own baseline control, and deviations rather than absolute values are preferred for analysis.

Which temperature measurement method is most accurate?Implanted telemetry offers the highest temporal fidelity with minimal stress artifacts; rectal thermometry provides validated point measurements; infrared thermography adds localized gland surface information. Combining methods is recommended for robust, publication-quality datasets.

How frequently should temperature be recorded?A common schedule is every 2 to 4 hours for the first 24 hours after inoculation, followed by every 12 hours up to 72 hours. Continuous telemetry eliminates the need to preselect time points and captures transient peaks.

How are animal welfare and humane endpoints handled?Protocols are reviewed and approved by the institutional animal care and use committee before initiation. Analgesia plans, humane endpoints based on hypothermia thresholds, body weight loss limits, and clinical scoring are pre-defined, consistent with the 3Rs principles and applicable national laboratory animal regulations such as GB 14925.